HEADER TRANSFERASE 05-AUG-22 8ANS TITLE CRYSTAL STRUCTURE OF D1228V C-MET BOUND BY COMPOUND 1. COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATOCYTE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: HGF RECEPTOR,HGF/SF RECEPTOR,PROTO-ONCOGENE C-MET,SCATTER COMPND 5 FACTOR RECEPTOR,SF RECEPTOR,TYROSINE-PROTEIN KINASE MET; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MET; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE, INHIBITOR, AC-HELIX, CANCER, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR G.W.COLLIE REVDAT 3 31-JAN-24 8ANS 1 REMARK REVDAT 2 07-SEP-22 8ANS 1 JRNL REVDAT 1 31-AUG-22 8ANS 0 JRNL AUTH G.W.COLLIE,L.BARLIND,S.BAZZAZ,U.BORJESSON,I.L.DALE, JRNL AUTH 2 J.S.DISCH,S.HABESHIAN,R.JETSON,P.KHURANA,A.MADIN, JRNL AUTH 3 I.N.MICHAELIDES,L.PENG,A.SNIJDER,C.J.STUBBS JRNL TITL DISCOVERY OF A SELECTIVE C-MET INHIBITOR WITH A NOVEL JRNL TITL 2 BINDING MODE. JRNL REF BIOORG.MED.CHEM.LETT. V. 75 28948 2022 JRNL REFN ESSN 1464-3405 JRNL PMID 35987508 JRNL DOI 10.1016/J.BMCL.2022.128948 REMARK 2 REMARK 2 RESOLUTION. 2.01 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.8 (24-FEB-2021) REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.01 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.56 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 17824 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.232 REMARK 3 R VALUE (WORKING SET) : 0.229 REMARK 3 FREE R VALUE : 0.277 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.330 REMARK 3 FREE R VALUE TEST SET COUNT : 950 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 48 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.01 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.02 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.73 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 380 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.3218 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 360 REMARK 3 BIN R VALUE (WORKING SET) : 0.3231 REMARK 3 BIN FREE R VALUE : 0.3000 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.26 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 20 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2123 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 64 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 33.26 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.46 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -7.32720 REMARK 3 B22 (A**2) : -7.43770 REMARK 3 B33 (A**2) : 14.76500 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.290 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.233 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.196 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.230 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.196 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.909 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.880 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2218 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3018 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 728 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 357 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2218 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 289 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2030 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.06 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.99 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.14 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 5 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: {A|1053 - 1089} REMARK 3 ORIGIN FOR THE GROUP (A): 22.0573 -9.4930 -41.5892 REMARK 3 T TENSOR REMARK 3 T11: -0.0241 T22: -0.0025 REMARK 3 T33: -0.1184 T12: 0.0142 REMARK 3 T13: 0.0271 T23: 0.0120 REMARK 3 L TENSOR REMARK 3 L11: 3.3290 L22: 1.2683 REMARK 3 L33: 0.4378 L12: 0.1685 REMARK 3 L13: 0.4824 L23: 0.1910 REMARK 3 S TENSOR REMARK 3 S11: -0.0637 S12: 0.2264 S13: -0.1396 REMARK 3 S21: 0.1116 S22: 0.0271 S23: 0.0484 REMARK 3 S31: -0.0403 S32: 0.1340 S33: 0.0365 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: {A|1090 - 1213} REMARK 3 ORIGIN FOR THE GROUP (A): 13.1333 -13.0724 -31.2816 REMARK 3 T TENSOR REMARK 3 T11: -0.0072 T22: 0.0029 REMARK 3 T33: -0.0193 T12: 0.0031 REMARK 3 T13: -0.0015 T23: 0.0149 REMARK 3 L TENSOR REMARK 3 L11: 0.3757 L22: 0.2294 REMARK 3 L33: 0.7646 L12: 0.0369 REMARK 3 L13: -0.3953 L23: -0.2877 REMARK 3 S TENSOR REMARK 3 S11: -0.0426 S12: 0.0275 S13: -0.0239 REMARK 3 S21: -0.0398 S22: 0.0059 S23: -0.0278 REMARK 3 S31: 0.0531 S32: -0.0062 S33: 0.0367 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: {A|1214 - 1248} REMARK 3 ORIGIN FOR THE GROUP (A): 13.1839 -10.2389 -23.3150 REMARK 3 T TENSOR REMARK 3 T11: -0.0100 T22: -0.0171 REMARK 3 T33: -0.0122 T12: -0.0315 REMARK 3 T13: 0.0078 T23: -0.0124 REMARK 3 L TENSOR REMARK 3 L11: 0.5390 L22: 0.0473 REMARK 3 L33: 0.5130 L12: -0.5893 REMARK 3 L13: -1.0978 L23: -0.8935 REMARK 3 S TENSOR REMARK 3 S11: 0.0746 S12: -0.0052 S13: 0.1393 REMARK 3 S21: -0.0503 S22: -0.0949 S23: 0.0050 REMARK 3 S31: -0.0352 S32: 0.0683 S33: 0.0203 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: {A|1249 - 1295} REMARK 3 ORIGIN FOR THE GROUP (A): 9.1416 -5.9947 -9.8214 REMARK 3 T TENSOR REMARK 3 T11: -0.0194 T22: 0.0104 REMARK 3 T33: -0.0291 T12: -0.0176 REMARK 3 T13: -0.0052 T23: -0.0132 REMARK 3 L TENSOR REMARK 3 L11: 0.5453 L22: 0.5782 REMARK 3 L33: 1.0972 L12: 0.2475 REMARK 3 L13: -0.4187 L23: 0.3888 REMARK 3 S TENSOR REMARK 3 S11: 0.0162 S12: -0.0469 S13: 0.0647 REMARK 3 S21: -0.0624 S22: -0.0494 S23: -0.0057 REMARK 3 S31: -0.0285 S32: -0.0061 S33: 0.0332 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 SELECTION: {A|1296 - 1346} REMARK 3 ORIGIN FOR THE GROUP (A): 4.8813 -17.6281 -7.6893 REMARK 3 T TENSOR REMARK 3 T11: -0.0069 T22: 0.0265 REMARK 3 T33: -0.0646 T12: -0.0015 REMARK 3 T13: 0.0058 T23: -0.0248 REMARK 3 L TENSOR REMARK 3 L11: 0.2328 L22: 1.4583 REMARK 3 L33: 0.6415 L12: 0.4829 REMARK 3 L13: -0.3533 L23: -0.1803 REMARK 3 S TENSOR REMARK 3 S11: 0.0224 S12: -0.1182 S13: -0.0738 REMARK 3 S21: 0.1590 S22: -0.0426 S23: 0.0157 REMARK 3 S31: 0.0753 S32: -0.0278 S33: 0.0202 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8ANS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-AUG-22. REMARK 100 THE DEPOSITION ID IS D_1292124788. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-NOV-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97625 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : XIA2 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17868 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.010 REMARK 200 RESOLUTION RANGE LOW (A) : 35.560 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.01 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.04 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 6.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6SDC REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 36.34 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.93 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15 % PEG10K, 100 MM PCPT PH 7.5, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.44500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 48.09000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 26.41500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 48.09000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.44500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 26.41500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1051 REMARK 465 ASN A 1100 REMARK 465 ASP A 1101 REMARK 465 GLY A 1102 REMARK 465 TYR A 1230 REMARK 465 ASP A 1231 REMARK 465 LYS A 1232 REMARK 465 GLU A 1233 REMARK 465 TYR A 1234 REMARK 465 TYR A 1235 REMARK 465 SER A 1236 REMARK 465 VAL A 1237 REMARK 465 HIS A 1238 REMARK 465 ASN A 1239 REMARK 465 LYS A 1240 REMARK 465 THR A 1241 REMARK 465 GLY A 1242 REMARK 465 ALA A 1243 REMARK 465 LYS A 1244 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A1064 CG CD OE1 NE2 REMARK 470 HIS A1088 CG ND1 CD2 CE1 NE2 REMARK 470 ASP A1099 CG OD1 OD2 REMARK 470 LYS A1103 CG CD CE NZ REMARK 470 GLU A1120 CG CD OE1 OE2 REMARK 470 GLU A1127 CG CD OE1 OE2 REMARK 470 GLU A1172 CG CD OE1 OE2 REMARK 470 GLU A1214 CG CD OE1 OE2 REMARK 470 LYS A1215 CG CD CE NZ REMARK 470 MET A1229 CG SD CE REMARK 470 GLN A1258 CG CD OE1 NE2 REMARK 470 LYS A1259 CG CD CE NZ REMARK 470 ARG A1279 CD NE CZ NH1 NH2 REMARK 470 GLU A1306 CG CD OE1 OE2 REMARK 470 GLU A1314 CG CD OE1 OE2 REMARK 470 LYS A1318 CD CE NZ REMARK 470 GLU A1325 CG CD OE1 OE2 REMARK 470 GLU A1332 CG CD OE1 OE2 REMARK 470 ARG A1336 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A1132 -1.81 65.78 REMARK 500 SER A1152 61.77 -152.69 REMARK 500 ARG A1203 -14.68 72.94 REMARK 500 PHE A1216 33.37 70.24 REMARK 500 REMARK 500 REMARK: NULL DBREF 8ANS A 1052 1346 UNP P08581 MET_HUMAN 1052 1346 SEQADV 8ANS GLY A 1051 UNP P08581 EXPRESSION TAG SEQADV 8ANS VAL A 1228 UNP P08581 ASP 1228 ENGINEERED MUTATION SEQRES 1 A 296 GLY HIS ILE ASP LEU SER ALA LEU ASN PRO GLU LEU VAL SEQRES 2 A 296 GLN ALA VAL GLN HIS VAL VAL ILE GLY PRO SER SER LEU SEQRES 3 A 296 ILE VAL HIS PHE ASN GLU VAL ILE GLY ARG GLY HIS PHE SEQRES 4 A 296 GLY CYS VAL TYR HIS GLY THR LEU LEU ASP ASN ASP GLY SEQRES 5 A 296 LYS LYS ILE HIS CYS ALA VAL LYS SER LEU ASN ARG ILE SEQRES 6 A 296 THR ASP ILE GLY GLU VAL SER GLN PHE LEU THR GLU GLY SEQRES 7 A 296 ILE ILE MET LYS ASP PHE SER HIS PRO ASN VAL LEU SER SEQRES 8 A 296 LEU LEU GLY ILE CYS LEU ARG SER GLU GLY SER PRO LEU SEQRES 9 A 296 VAL VAL LEU PRO TYR MET LYS HIS GLY ASP LEU ARG ASN SEQRES 10 A 296 PHE ILE ARG ASN GLU THR HIS ASN PRO THR VAL LYS ASP SEQRES 11 A 296 LEU ILE GLY PHE GLY LEU GLN VAL ALA LYS GLY MET LYS SEQRES 12 A 296 TYR LEU ALA SER LYS LYS PHE VAL HIS ARG ASP LEU ALA SEQRES 13 A 296 ALA ARG ASN CYS MET LEU ASP GLU LYS PHE THR VAL LYS SEQRES 14 A 296 VAL ALA ASP PHE GLY LEU ALA ARG VAL MET TYR ASP LYS SEQRES 15 A 296 GLU TYR TYR SER VAL HIS ASN LYS THR GLY ALA LYS LEU SEQRES 16 A 296 PRO VAL LYS TRP MET ALA LEU GLU SER LEU GLN THR GLN SEQRES 17 A 296 LYS PHE THR THR LYS SER ASP VAL TRP SER PHE GLY VAL SEQRES 18 A 296 LEU LEU TRP GLU LEU MET THR ARG GLY ALA PRO PRO TYR SEQRES 19 A 296 PRO ASP VAL ASN THR PHE ASP ILE THR VAL TYR LEU LEU SEQRES 20 A 296 GLN GLY ARG ARG LEU LEU GLN PRO GLU TYR CYS PRO ASP SEQRES 21 A 296 PRO LEU TYR GLU VAL MET LEU LYS CYS TRP HIS PRO LYS SEQRES 22 A 296 ALA GLU MET ARG PRO SER PHE SER GLU LEU VAL SER ARG SEQRES 23 A 296 ILE SER ALA ILE PHE SER THR PHE ILE GLY HET GOL A1401 6 HET MDI A1402 34 HETNAM GOL GLYCEROL HETNAM MDI 3-[BIS(FLUORANYL)METHYL]-~{N}-METHYL-~{N}-[(1~{R})-8- HETNAM 2 MDI METHYL-5-(3-METHYL-1~{H}-INDAZOL-6-YL)-1,2,3,4- HETNAM 3 MDI TETRAHYDRONAPHTHALEN-1-YL]PYRIDINE-2-CARBOXAMIDE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 GOL C3 H8 O3 FORMUL 3 MDI C27 H26 F2 N4 O FORMUL 4 HOH *64(H2 O) HELIX 1 AA1 ASN A 1059 VAL A 1069 1 11 HELIX 2 AA2 ARG A 1114 VAL A 1121 5 8 HELIX 3 AA3 SER A 1122 LYS A 1132 1 11 HELIX 4 AA4 ASP A 1164 ASN A 1171 1 8 HELIX 5 AA5 THR A 1177 LYS A 1198 1 22 HELIX 6 AA6 ALA A 1206 ARG A 1208 5 3 HELIX 7 AA7 PRO A 1246 MET A 1250 5 5 HELIX 8 AA8 ALA A 1251 GLN A 1258 1 8 HELIX 9 AA9 THR A 1261 THR A 1278 1 18 HELIX 10 AB1 ASN A 1288 PHE A 1290 5 3 HELIX 11 AB2 ASP A 1291 GLN A 1298 1 8 HELIX 12 AB3 PRO A 1309 TRP A 1320 1 12 HELIX 13 AB4 LYS A 1323 ARG A 1327 5 5 HELIX 14 AB5 SER A 1329 SER A 1342 1 14 SHEET 1 AA1 6 VAL A1070 ILE A1071 0 SHEET 2 AA1 6 GLY A1144 CYS A1146 1 O ILE A1145 N ILE A1071 SHEET 3 AA1 6 LEU A1154 PRO A1158 -1 O VAL A1156 N GLY A1144 SHEET 4 AA1 6 ILE A1105 SER A1111 -1 N LYS A1110 O VAL A1155 SHEET 5 AA1 6 GLY A1090 LEU A1097 -1 N TYR A1093 O VAL A1109 SHEET 6 AA1 6 LEU A1076 GLY A1087 -1 N GLU A1082 O HIS A1094 SHEET 1 AA2 2 PHE A1200 VAL A1201 0 SHEET 2 AA2 2 ARG A1227 VAL A1228 -1 O ARG A1227 N VAL A1201 SHEET 1 AA3 2 CYS A1210 LEU A1212 0 SHEET 2 AA3 2 VAL A1218 VAL A1220 -1 O LYS A1219 N MET A1211 CRYST1 50.890 52.830 96.180 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019650 0.000000 0.000000 0.00000 SCALE2 0.000000 0.018929 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010397 0.00000